Top food safety leader at the U. S. medical watchdog has just quit. That means long-planned rules about junk food, school meals, and toxic chemicals may never happen. For years, the food industry knew this person as the one pushing for stricter rules on snacks, drinks, and baby food. Officials had
A sudden shake-up is coming in Washington’s health leadership. Dr. Marty Makary, who has been leading the FDA for just over a year, appears set to leave his post. The move follows months of behind-the-scenes tension and multiple reports predicting his departure. His exit adds another empty chair at
The U. S. government recently took a sharp turn from its long fight against flavored vapes. For years, officials worked hard to block fruit and candy flavors, arguing they hook young users. Now, suddenly, the same agency that once banned over a million flavors has greenlit four new ones—all aimed at
The U. S. Food and Drug Administration has finally cleared fruit‑tasting e‑cigarettes for sale, a first in the country. The decision clears pods from Glas Inc. , a Los Angeles company that employs age‑verification tech to keep young people out. The flavors include mango, blueberry and two menthol op
The buzz around ibogaine, a plant‑derived drug from West Africa, exploded when a U. S. president highlighted its promise at a White House event that celebrated psychedelic research. For the first time, the Food and Drug Administration has cleared a clinical trial to test the substance in people.
Doctors in the U. S. now have another tool to fight a tough cancer. The FDA gave the green light for early use of an experimental pill called daraxonrasib. It targets pancreatic ductal adenocarcinoma, a fast-spreading form of pancreatic cancer that has already resisted other treatments. Patients who
For decades, drug testing followed the same slow rhythm. Researchers ran trials in stages, then paused for months to analyze data before asking regulators for the next step. Patients waited years for treatments while paperwork piled up. Now, a new FDA approach cuts out the waiting by letting regulat
The Food and Drug Administration is preparing for a new leader at its Center for Biologics Evaluation and Research. Last month the agency announced that Vinay Prasad, who has worked as an oncologist and was vocal about U. S. drug policies, would step down by the end of April. The decision to replace
Peptides are tiny chains of amino acids that some people inject hoping for big results. They’re marketed for faster healing, better skin, stronger muscles, and more energy. Influencers and athletes swear by them, but most peptides lack strong scientific proof. Without clear research, users are essen
The U. S. health watchdog is about to check if some lab-made peptides can be mixed freely in pharmacies. Peptides—tiny protein pieces—are popping up in treatments for everything from sleep troubles to weight loss. Yet most of these mixes skip the usual safety checks. A panel will meet in late July
